Hesai Group reported better-than-expected revenue for Q3 2026, driven by strong growth in its SGI segment, which doubled revenue sequentially and exceeded full-year targets. However, the company missed earnings per share (EPS) estimates and issued Q4 revenue guidance significantly below consensus, citing challenges like ADAS price erosion and a weak auto market. Risks include customer concentration, dependence on Dreame, and regulatory concerns. Despite a strong cash position providing some safety, consistent execution and market recovery are needed for a more optimistic outlook.
Hesai Group's Q3 2026 results provide context for readers interested in technology-sector trends. For readers following this sector, here is Pluang's market snapshot as of Nov 12, 2026 20:21 WIB: out of 150 priced US tech stocks, 25 rose and 121 fell. Among notable movers, Applied Digital Corporation (APLD) traded at USD 16.98 with a 5.19% decline and a strong buy order activity of 85%, while Aehr Test Systems (AEHR) and Micron Technology (MU) also saw similar declines of around 5.17% and 5.16% respectively, with MU showing the longest typical hold time of 52 days and the highest buy order activity at 87%.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
